Login / Signup
Risks of Treating Idiopathic Pulmonary Fibrosis with a TAM Receptor Kinase Inhibitor.
Corina N D'Alessandro-Gabazza
Tetsu Kobayashi
Esteban Cesar Gabazza
Published in:
American journal of respiratory and critical care medicine (2019)
Keyphrases
</>
rheumatoid arthritis
idiopathic pulmonary fibrosis
interstitial lung disease
human health
binding protein